Skip to main content

FDA recall, , High risk

B. Braun Lactated Ringer's Injection

Lactated Ringer's Injection may contain particulate matter that can cause patient harm.

What happened

B. Braun Medical Inc., of Allentown, Pennsylvania, recalled 95,412 containers of Lactated Ringer's Injection USP, 1000 mL, Rx only, because the products were found to contain particulate matter in solution. The recall began on April 28, 2026, and was added to the FDA's Enforcement Report on May 6, 2026, with classification on May 18, 2026.

The product is distributed nationwide in the U.S.A. The recalled containers are from B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA.

What to do

If a code on your package is listed below:

  1. Consumers and distributors that have product which is being recalled should stop using and arrange for return of the product using the Urgent Pharmaceutical Recall Acknowledgement form provided by the company.
  2. Consumers with questions regarding this recall can contact B. Braun’s Recalls Department at 844-903-6417 or recalls@bbraunusa.com, Monday to Friday from 8:00 am to 5:00 pm EST.
  3. Contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.

Is yours affected?

Match the NDC and lot code listed under your product.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Lactated Ringer's Injection USP

    NDC
    • 0264-7750-07
    Lot code
    • J4P756
    • J4S843

Recall details

Company began the recall
Sold in

U.S.A. Nationwide

Company
B Braun Medical IncAllentown, Pennsylvania
Risk

High risk

There is a reasonable chance that taking it could cause serious health problems or death.

FDA Class I recall · How risk is rated

Event ID
98795
Recall number
D-0540-2026
Quantity recalled
95,412 containers

All recalls from B Braun Medical Inc

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall · Announced by the company

  2. Added to FDA's Enforcement Report

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Classified by FDA

  6. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 7, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)